Table 2.
Study | Primary outcome | Secondary outcomes | ||||
---|---|---|---|---|---|---|
Incidence of VAP | ICU mortality | Length of ICU stay, days | Duration of MV, days | Antibiotic-free day, days | MV-free day, days | |
Munro et al. [20] (2009) | 48/97 vs. 45/95 | 22/97 vs. 22/95 | NR | NR | NR | NR |
Pobo et al. [21] (2009) | 15/74 vs. 18/73 | 16/74 vs. 23/73 | 12.9 ± 8.7 vs. 15.5 ± 9.6 | 8.9 ± 5.8 vs. 9.8 ± 6.1 | 7.6 ± 8.4 vs. 7.8 ± 7.6 | 9.5 ± 12.2 vs. 11.3 ± 12.3 |
Yao et al. [22] (2011) | 4/28 vs. 14/25 | NR | 12.5 ± 6.1 vs. 13.5 ± 6.8 | 12.0 ± 11.0 vs. 13.6 ± 15.6 | NR | NR |
Lorente et al. [23] (2012) | 21/217 vs. 24/219 | 62/217 vs. 69/219 | 12.07 ± 15.55 vs. 13.04 ± 17.27 | 9.18 ± 14.13 vs. 9.93 ± 15.39 | 7.43 ± 14.84 vs. 8.39 ± 16.83 | 4.03 ± 3.22 vs. 4.42 ± 3.93 |
ICU, intensive care unit; MV, mechanical ventilation; NR, not reported; VAP, ventilator-associated pneumonia.